713 related articles for article (PubMed ID: 30382336)
1. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).
Khalid M; Andreoli S
Pediatr Nephrol; 2019 Dec; 34(12):2495-2507. PubMed ID: 30382336
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
[TBL] [Abstract][Full Text] [Related]
3. Hemolytic uremic syndrome in children.
Talarico V; Aloe M; Monzani A; Miniero R; Bona G
Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and Treatment for Shiga Toxin-Producing
Liu Y; Thaker H; Wang C; Xu Z; Dong M
Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668830
[TBL] [Abstract][Full Text] [Related]
5. Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2.
Wijnsma KL; Schijvens AM; Rossen JWA; Kooistra-Smid AMDM; Schreuder MF; van de Kar NCAJ
Pediatr Nephrol; 2017 Jul; 32(7):1263-1268. PubMed ID: 28343354
[TBL] [Abstract][Full Text] [Related]
6. Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial).
Freedman SB; Schnadower D; Estes M; Casper TC; Goldstein SL; Grisaru S; Pavia AT; Wilfond BS; Metheney M; Kimball K; Tarr PI;
Trials; 2023 May; 24(1):359. PubMed ID: 37245030
[TBL] [Abstract][Full Text] [Related]
7. Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.
Bai X; Ylinen E; Zhang J; Salmenlinna S; Halkilahti J; Saxen H; Narayanan A; Jahnukainen T; Matussek A
Microbiol Spectr; 2022 Aug; 10(4):e0066022. PubMed ID: 35730965
[TBL] [Abstract][Full Text] [Related]
8. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A
BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
[TBL] [Abstract][Full Text] [Related]
10. Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage.
Luna M; Kamariski M; Principi I; Bocanegra V; Vallés PG
Pediatr Nephrol; 2021 Jun; 36(6):1499-1509. PubMed ID: 33205220
[TBL] [Abstract][Full Text] [Related]
11. Hemolytic uremic syndrome with mild renal involvement due to Shiga toxin-producing Escherichia coli (STEC) O145 strain.
Pérez L; Apezteguía L; Piñeyrúa C; Dabezies A; Bianco MN; Schelotto F; Varela G
Rev Argent Microbiol; 2014; 46(2):103-6. PubMed ID: 25011592
[TBL] [Abstract][Full Text] [Related]
12. [Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].
Bertholet-Thomas A; Ranchin B; King LA; Bacchetta J; Belot A; Gillet Y; Collardeau-Frachon S; Cochat P
Arch Pediatr; 2011 Jul; 18(7):823-30. PubMed ID: 21571510
[TBL] [Abstract][Full Text] [Related]
13. Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.
Peco-Antić A
Srp Arh Celok Lek; 2016; 144(11-12):664-9. PubMed ID: 29659236
[TBL] [Abstract][Full Text] [Related]
14. Clostridium septicum infection complicating Hemolytic-Uremic Syndrome: a case report and review of the literature.
Cirillo L; Noris A; Odone L; Giordano F; Becherucci F
J Nephrol; 2024 Jan; 37(1):181-186. PubMed ID: 37314614
[TBL] [Abstract][Full Text] [Related]
15. STEC colitis mimicking acute severe colitis with life-threatening consequences: a case report.
Hendrickx T; Peetermans M; D'Hoore A; Claes K; Van Hootegem A; Sabino J
Acta Gastroenterol Belg; 2024; 87(1):37-39. PubMed ID: 38431789
[TBL] [Abstract][Full Text] [Related]
16. Acute peritoneal dialysis, complications and outcomes in 389 children with STEC-HUS: a multicenter experience.
Coccia PA; Ramírez FB; Suárez ADC; Alconcher LF; Balestracci A; García Chervo LA; Principi I; Vázquez A; Ratto VM; Planells MC; Montero J; Saurit M; Gutiérrez MGPY; Puga MC; Isern EM; Bettendorff MC; Boscardin MV; Bazán M; Polischuk MA; De Sarrasqueta A; Aralde A; Ripeau DB; Leroy DC; Quijada NE; Escalante RS; Giordano MI; Sánchez C; Selva VS; Caminiti A; Ojeda JM; Bonany P; Morales SE; Allende D; Arias MA; Exeni AM; Geuna JD; Arrúa L
Pediatr Nephrol; 2021 Jun; 36(6):1597-1606. PubMed ID: 33394193
[TBL] [Abstract][Full Text] [Related]
17. Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.
Mahat U; Matar RB; Rotz SJ
Pediatr Blood Cancer; 2019 Nov; 66(11):e27913. PubMed ID: 31286658
[TBL] [Abstract][Full Text] [Related]
18. [Hemolytic uremic syndrome caused by Shiga-toxin-producing Escherichia coli].
Loirat C
Rev Prat; 2013 Jan; 63(1):11-6. PubMed ID: 23457821
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin-Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial.
Garnier A; Brochard K; Kwon T; Sellier-Leclerc AL; Lahoche A; Launay EA; Nobili F; Caillez M; Taque S; Harambat J; Michel-Bourdat G; Guigonis V; Fila M; Cloarec S; Djamal-Dine D; de Parscaux L; Allard L; Salomon R; Ulinski T; Frémeaux-Bacchi V; Morin C; Olivier-Abbal P; Colineaux H; Auriol F; Arnaud C; Kieffer I; Brusq C
J Am Soc Nephrol; 2023 Sep; 34(9):1561-1573. PubMed ID: 37303085
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
